Companies Dominating the Methadone Landscape
- Eli Lilly and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sanofi S.A.
- Hikma Labs Inc.
- Mallinckrodt Pharmaceuticals
- Siegfried Holding AG
- Johnson Matthey
- Gilead Sciences, Inc.
- BioControl Medical
- Tianjin Central Pharmaceutical Industry Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of methadone is evaluated at USD 193.93 million.
The methadone market size was over USD 172.86 million in 2024 and is poised to exceed USD 437.27 million by 2037, witnessing over 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing demand for methadone rehabilitation of heroin addicts will drive the market growth.
North America industry is likely to account for largest revenue share of 42% by 2037, driven by increasing cases of drug addiction in the region.
The major players in the market are Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
